Physician profile
Deepak K Das
NPI 1912908070
$1,374.36
in general payments reported to CMS, 2019-2025
17 companies · $335 in 2025
The $335 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.70 · 2020: $320 · 2021: $191 · 2022: $147 · 2023: $157 · 2024: $155 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548 · Education: $97.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.34 |
| Education | $97.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $246.60 | 2020-2025 | |
| Jazz Pharmaceuticals INC. | $235.48 | 2020-2025 | |
| Abbott Laboratories | $173.06 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Astellas Pharma US INC | $115.38 | 2019-2024 | Veozah |
| Novo Nordisk INC | $106.24 | 2020-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $105.78 | 2020-2025 | Trulicity, Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $102.00 | 2023-2025 | Gemtesa, Myfembree |
| Vanda Pharmaceuticals INC. | $94.82 | 2020 | |
| Axsome Therapeutics, INC. | $45.01 | 2023-2024 | Sunosi |
| Resmed Corp | $30.77 | 2023-2025 | |
| Abbvie INC. | $21.71 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $18.45 | 2024 | Lumryz |
| Verona Pharma, INC. | $17.44 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $17.08 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.74 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $16.05 | 2021 | |
| Eisai INC. | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.